Orexigen Therapeutics, Inc. news

   Watch this stock
Showing stories 1 - 10 of about 76   

Articles published

OREX 5.89 +0.01 (0.17%)
price chart
Why Orexigen Therapeutics, Inc. Stock Skyrocketed
What: Shares of Orexigen Therapeutics (NASDAQ: OREX ) , a biopharmaceutical company focused on developing therapies to treat obesity, surged higher by as much as 33% after the company reported its third-quarter earnings results and provided an ...
Orexigen Therapeutics (OREX) Stock Soars Today on Big Third Quarter ...  TheStreet.com
Orexigen Therapeutics rises as European Union review of weight loss drug ...  Fox Business
Related articles »  
Stock Update: Orexigen Therapeutics, Inc. (NASDAQ:OREX)
[PR Newswire] Orexigen Therapeutics, Inc. (NASDAQ:OREX) (Trend Analysis) announced that the Company has received a notice of allowance from the U.S.
Morning Movers: PPL Corporation (PPL), On Track Innovations Ltd. (OTIV ...  WallStreet Scope
Investor Alert on Insider Trading:The Cheesecake Factory Inc , Orexigen ...  The Daily Joplin
Related articles »  
How Bad Is This Delay for Orexigen Therapeutics, Inc?
Orexigen Therapeutics (NASDAQ: OREX ) recently announced that the Food and Drug Administration was delaying an approval decision on the biotech's obesity drug Contrave for three months.
Not Even a Weight Loss Drug Could Stop Orexigen Therapeutics, Inc. From ...
Those fears have sparked a flurry of research and development into drugs that could help reduce the risk of type 2 diabetes by helping patients lose weight, including Orexigen Therapeutics' (NASDAQ: OREX ) recently approved Contrave. Yet despite ...
Related articles »  
What's Driving Orexigen Therapeutics Higher?
The rally in shares of Orexigen Therapeutics, Inc. (NASDAQ: OREX) that started on Monday, doesn't seem to be coming to an end anytime soon.
Health Sector Most Volatile Stocks- Orexigen Therapeutics, Inc. (NASDAQ:OREX ...  StreetWise Report
Trend Analysis Report- Macy's, Inc. (NYSE:M), Orexigen Therapeutics, Inc ...  Techsonian (press release)
Related articles »  
Today's Perilous Reversal Stock: Orexigen Therapeutics (OREX)
Orexigen Therapeutics, Inc., a biopharmaceutical company, focuses on the development of pharmaceutical product candidates for the treatment of obesity.
Related articles »  
Orexigen Therapeutics Continues to Rally
Caesars Entertainment Corp (NASDAQ:CZR), Orexigen Therapeutics, Inc. (NASDAQ:OREX) and Fossil Group Inc (NASDAQ:FOSL) reached midday with major gains.
Orexigen Therapeutics's Neutral Rating Reaffirmed at Zacks (OREX)  WKRB News
Orexigen Therapeutics Rating Reiterated by Wells Fargo & Co. (OREX)  Watch List News (press release)
Related articles »  
2 Skyrocketing Biotech Stocks In A Stalling Market
Last week's market price action was somewhat like watching paint peel. In other words, there just wasn't much going on. Even though the market edged higher for the fourth straight week and the S&P 500 hit new record highs, the gains came during the ...
Insider Buying: Orexigen Therapeutics Director Buys 27052 Shares of Stock ...  The Legacy
Biotech Equities Technical Coverage - Orexigen Therapeutics, Novavax ...  SYS-CON Media (press release)
Related articles »  
Orexigen Therapeutics Inc. (OREX) Jumps 33.25% on November 10
Orexigen Therapeutics Inc. (OREX) was among the biggest gainers on the Russell 2000 for November 10 as the stock popped 33.25% to $5.13, representing a gain of $1.28 per share.
Related articles »  
Orexigen Therapeutics Has Substantial Upside For Bull Investors (OREX)
Orexigen recently struck a deal with Takeda for the commercialization of OREX anti-obesity drug Contrave. Orexigen is currently awaiting EU approval to distribute Contrave throughout European medicinal markets.
Related articles »